A mammogram has always been a snapshot of now. An image of what already exists, seen too often after it’s too late. But now, a machine has learned to see what isn’t there yet.
Clairity Breast, freshly approved by the FDA, scans routine mammograms to predict a woman’s five-year breast cancer risk — not by spotting a tumor, but by detecting invisible patterns in healthy tissue, years before symptoms appear.
In India, where breast cancer is the most common cancer in women and half the cases are caught too late, this matters. Because here, cancer rarely waits for the textbook signs. It finds the young, the working, the caregivers, the ones too busy or too hesitant for regular screenings.
This AI offers time. Not a guarantee, but a chance. A nudge before the crisis, a warning before the silence turns serious.
Progress doesn’t always arrive with noise. Sometimes it comes as a quiet tool — and in places where too many stories go unheard, that’s enough to change them.